Brief: Cardiff Oncology Posts Quarterly Loss Per Share Of $0.17
04/11/2021 22:41
Nov 4 (Reuters) - Cardiff Oncology Inc CRDF.O :
* CARDIFF ONCOLOGY REPORTS THIRD QUARTER 2021 RESULTS AND
PROVIDES
BUSINESS UPDATES
* CASH, CASH EQUIVALENTS, AND SHORT-TERM INVESTMENTS OF
APPROXIMATELY $134 MILLION AS OF SEPTEMBER 30, 2021
* QTRLY LOSS PER SHARE $0.17
* Q3 EARNINGS PER SHARE VIEW $-0.17 -- REFINITIV IBES DATA
Source text for Eikon: ID:nPn9BPkqMa
Further company coverage: CRDF.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Cardiff Oncology
See all newsBrief: Cardiff Oncology Receives FDA Orphan Drug Designation For Onvansertib In Chronic Myelomonocytic Leukemia
Corrected: Cardiff Oncology Q2 operating expenses fall on lower R&D costs
Cardiff Oncology Inc expected to post a loss of 16 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Cintas, Veradermics
Cardiff Oncology sinks on direct equity offering